US$ 22.39
affordable glp-1 alternatives How Much Does Cost? Understand Pricing and Patients Are Left With Few
Description
With more generic pharmaceuticals hitting the market, the glucagon-like peptide 1 (GLP-1) agonists market is expected to develop in the region

An exploratory cohort of subjects was also evaluated to assess changes to dose regimen
Available as: Last cited 8 Sept 2023 Ethics declarations Ethics approval and consent to participate Since it is a review article, they are not required

Dardano A, Bianchi C, Garofolo M, Del Prato S

That positions GLP-1s as disease-modifying therapy, not just weight loss drugs

F.de MouraR
